Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$277,316
-$28,601 QoQ
Shares Held
2,195
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,704
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026St. Louis Trust Co holds $9,366,511 across 8 Drug Manufacturers - General names. GILD ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
16,457 | $2,114,724 | |
| 2 | ABBV |
AbbVie Inc.
|
8,278 | $2,083,075 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
33,158 | $1,910,563 | |
| 4 | PFE |
Pfizer Inc
|
53,894 | $1,297,767 | |
| 5 | LLY |
ELI LILLY & Co
|
773 | $927,159 | |
| 6 | JNJ |
Johnson & Johnson
|
2,051 | $520,892 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,195 | $277,316 | |
| 8 | AMGN |
Amgen Inc
|
649 | $235,015 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,316 | 2,195 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $305,917 | 2,195 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $269,414 | 2,195 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $243,645 | 2,195 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $243,359 | 2,195 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $245,949 | 2,195 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||